Viwit is dedicated to the development and production of borane products, pharmaceutical intermediates and APIs. Viwit has 3 integrated product R&D centers, 3 cGMP production facilities. The marketing system covers China, Russia, the US, Canada, Latin America, the European Union, etc. Viwit has developed and manufactures more than 35 generic APIs and formulations, mainly in diabetes, anti-fungal, ophthalmic, oncology, smoking cessation, MRI contrast agent and cardiovascular therapeutic areas.